Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Honeywell International Inc (HON) vs Sanofi SA (SNY) Price & Performance

Honeywell International IncTrade
Sanofi SATrade

Price performance (Past 24H)

Key statistics

Honeywell International Inc vs Sanofi SA — how do they compare? Honeywell International Inc trades at $229.74 (market cap $71.66B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.

HONSNY
Market Cap
$71.66B$104.83B
Sector
IndustrialsHealth
52-Week High
$248.04$52.34
52-Week Low
$188.14$41.33
Enterprise Value
$96.01B$121.32B
Dividend Yield
4.21%5.5%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Honeywell International Inc

Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.

Read more on HON

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY